1. FRI0223 Long-term targeted safety event rates in ra patients following initiation of rituximab: interim analysis from sunstone registry. (23rd January 2014) Authors: Furst, D.; Winthrop, K. L.; Alexander, K. A.; Vashishtha, A.; Francom, S. F.; Saag, K. G. Journal: Annals of the rheumatic diseases Issue: Volume 72:Supplement 3(2013) Page Start: A448 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. FRI0529 Comparative risks for serious infections associated with biologics in high risk rheumatoid arthritis patients. (23rd January 2014) Authors: Yun, H.; Xie, F.; Delzell, E.; Chen, L.; Levitan, E.; Lewis, J.; Saag, K. G.; Beukelman, T.; Winthrop, K. L.; Baddley, J. W.; Muntner, P.; Curtis, J. R. Journal: Annals of the rheumatic diseases Issue: Volume 72:Supplement 3(2013) Page Start: A553 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. OP0163 Evaluation of Influenza and Pneumococcal Vaccine Responses in Rheumatoid Arthritis Patients Using Tofacitinib. (23rd January 2014) Authors: Winthrop, K. L.; Neal, J.; Hrycaj, P.; Soma, K.; Wilkinson, B.; Hodge, J.; Zwillich, S. H.; Wang, T.; Rottinghaus, S.; Kawabata, T.; Riese, R.; Mebus, C.; Bradley, J. D.; Bingham, C. O. Journal: Annals of the rheumatic diseases Issue: Volume 72:Supplement 3(2013) Page Start: A107 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗